20392-34-1

Usage

Uses

Used in the Polyurethane Industry:
2-Ethylhexyl isocyanate 98 is used as a key raw material for the production of polyurethane foams. It contributes to the formation of flexible and rigid foams, which are utilized in a wide range of applications, including furniture, bedding, insulation, and automotive components.
Used in the Coatings Industry:
In the coatings industry, 2-Ethylhexyl isocyanate 98 is used as a component in the formulation of various types of coatings. Its ability to rapidly polymerize and crosslink with other compounds results in coatings with enhanced durability, adhesion, and resistance to environmental factors.
Used in the Adhesives Industry:
2-Ethylhexyl isocyanate 98 is used as a raw material in the production of adhesives. Its reactivity allows for the creation of strong bonds between different materials, making it suitable for use in various applications, such as construction, automotive, and packaging industries.
Used in the Elastomers Industry:
In the elastomers industry, 2-Ethylhexyl isocyanate 98 is used to produce materials with high elasticity and flexibility. These elastomers are employed in a variety of applications, including seals, gaskets, and hoses, where their ability to withstand deformation and maintain their properties is crucial.
Safety Precautions:
Due to the reactivity and potential health hazards associated with 2-Ethylhexyl isocyanate 98, it is essential to handle and store this chemical compound with caution. Proper safety protocols, including the use of personal protective equipment and adherence to storage guidelines, should be followed to minimize risks.

Upstream product

• 75-44-5 phosgene 
• 104-75-6 2-Ethylhexylamine 
• 503-38-8 trichloromethyl chloroformate 
• 32315-10-9 bis(trichloromethyl) carbonate 

Downstream Products

• 1256739-49-7 1-(2-ethylhexyl)-3-(2-methyl-5-nitrophenyl)urea 
• 23747-90-2 1-(2-ethylhexyl)-3-(4-(trifluoromethyl)phenyl)urea 
• 1610701-92-2 1-(2-ethylhexyl)-3-(2-ethynylphenyl)urea 
• 1326247-01-1 C₂₀H₃₉N₃O₃ 
• 1326247-03-3 C₂₀H₃₉N₃O₃ 
• 1326247-15-7 C₂₇H₄₀N₄O₂ 
• 1326247-14-6 C₂₇H₄₀N₄O₂ 
• 1326247-13-5 C₂₅H₄₃N₅O₂ 
• 1326247-12-4 C₂₅H₄₃N₅O₂ 
• 1326247-09-9 C₃₃H₄₂N₄O₂ 
• 1326247-06-6 C₃₃H₄₂N₄O₂ 
• 1326247-05-5 C₁₅H₃₁N₃O 
• 1326247-04-4 C₁₅H₃₁N₃O 
• 37801-30-2 (2-Ethyl-hexyl)-carbamic acid 3-ethylsulfanylcarbonylamino-phenyl ester 

Relevant academic research and scientific papers

CLEAVABLE ADDITIVES FOR USE IN A METHOD OF MAKING A SEMICONDUCTOR SUBSTRATE

The use of an organic compound as cleavable additive, preferably as cleavable surfactant, in the modification and/or treatment of at least one surface of a semiconductor substrate is described. Moreover, it is described a method of making a semiconductor substrate, comprising contacting at least one surface thereof with an organic compound, or with a composition comprising it, to treat or modify said surface, cleaving said organic compound into a set of fragments and removing said set of fragments from the contacted surface. More in particular, a method of cleaning or rinsing a semiconductor substrate or an intermediate semiconductor substrate is described. In addition, a compound is described which is suitable for the uses and methods pointed out above and which preferably is a cleavable surfactant.

COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS

The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.

Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates

A series of imidazole-containing (non-)chiral carbamates were tested at human histamine H3 receptor (H3R). All compounds displayed Ki values below 100 nM. A trend for a stereoselectivity at human H3R was observed for the chiral α-branched ligands. Selected compounds were also tested at human histamine H4 receptor and showed moderate to weak affinities (118-1460 nM).

Importance of the lipophilic group in carbamates having histamine H3- receptor antagonist activity

In order to evaluate changes in the lipophilic part of designed carbamates concerning their potential histamine H3-receptor antagonist properties a new series of O-[3-(1H-imidazol-4-yl)propanol]carbamates was derived containing N-mono- or dialkenyl, alkynyl, cycloalkyl, or double- branched alkyl substituents. The compounds were tested in vitro for their H3-receptor antagonist activity on synaptosomes of rat cerebral cortex and shared moderate to high antagonist activity in vitro. In this series 3-(1H- imidazol-4-yl)propyl N-(4-pentenyl)carbamate (4) was the most potent compound in vitro (K(i) = 6.3 nM). H3-receptor antagonist activity in the central nervous system (CNS) was detected for most compounds in the in vivo H3- receptor assay based upon measurement of brain N(τ)-methylhistamine levels after p.o. administration to mice. The most effective carbamate in vivo, 3- (1H-imidazol-4-yl)propyl N-(allyl)carbamate (3), showed higher CNS potency (ED50 = 0.48 mg/kg p.o.) than the reference antagonist thioperamide. For some novel carbamates their histamine H1- and H2-receptor activities were determined on isolated organs of guinea-pig thereby demonstrating their high H3-receptor selectivity.